Page last updated: 2024-10-17

3-hydroxybutyric acid and Hyperamylasemia

3-hydroxybutyric acid has been researched along with Hyperamylasemia in 1 studies

3-Hydroxybutyric Acid: BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
3-hydroxybutyric acid : A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.

Hyperamylasemia: A condition with abnormally elevated level of AMYLASES in the serum. Hyperamylasemia due to PANCREATITIS or other causes may be differentiated by identifying the amylase isoenzymes.

Research Excerpts

ExcerptRelevanceReference
"Acute pancreatitis and hyperamylasemia are often seen in patients with acute liver failure (ALF)."1.72β-hydroxybutyrate inhibits ferroptosis-mediated pancreatic damage in acute liver failure through the increase of H3K9bhb. ( Chen, J; Cui, B; Li, B; Li, X; Liu, J; Liu, L; Shan, C; Sun, N; Sun, W; Xing, H; Xu, Q; Yang, T; Zheng, Y; Zhu, W, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zheng, Y1
Sun, W1
Shan, C1
Li, B1
Liu, J1
Xing, H1
Xu, Q1
Cui, B1
Zhu, W1
Chen, J1
Liu, L1
Yang, T1
Sun, N1
Li, X1

Other Studies

1 other study available for 3-hydroxybutyric acid and Hyperamylasemia

ArticleYear
β-hydroxybutyrate inhibits ferroptosis-mediated pancreatic damage in acute liver failure through the increase of H3K9bhb.
    Cell reports, 2022, 12-20, Volume: 41, Issue:12

    Topics: 3-Hydroxybutyric Acid; Acute Disease; Animals; Ferroptosis; Hyperamylasemia; Liver Failure, Acute; M

2022